While the socio-economic impact of translational medicine is the most obvious, EATRIS’ efforts serving industry since its inception should be celebrated reducing barriers to public-private collaboration, and knowledge sharing. Additional efforts to be highlighted include to the mentoring and translational services offered to SMEs. Although the services are delivered to researcher funders, start-ups and biotech companies are the main beneficiary, provided with strong knowledge and support for their products portfolio development, strong understanding of IP and market analysis together with regulatory and health technology assessment expertise.
Stories:
- GSK hub
- Human+
- Public-private collaboration workshop
- EATRIS work fostering Industry-Academia collaborations
- Codex4SMEs
